Seminar Series

Policy Modeling at the Intersection of Drug and Infectious Disease Epidemics

March 12, 2018
12:00 PM - 1:00 PM
Jeremy Goldhaber-Fiebert, PhD
Associate Professor of Medicine, Stanford University
Public Health 1149, Pitt Public Health
Sharon Crow
Project Coordinator


In the United States, worrisome shifts and upsurges in the epidemiology of HIV and hepatitis C virus (HCV) are thought to be driven by shifting patterns of risk behaviors, both in terms of injection drug use and sexual behaviors. Increased incidence has occurred in subgroups defined in terms of age, sex, risk behaviors, and geography. Proposed policies to address such threats frequently involve targeting specific subgroups and the use of multiple, simultaneous interventions. I describe the development, calibration, and validation of a microsimulation model which captures injection and non-injection use of opioids and stimulants; heterosexual, homosexual, and bisexual age-specific mixing; and HIV, HCV, and co-infection to represent various geographic settings in the United States. I then use the model to illustrate the multiple effects of various interventions that target specific diseases and/or risk behaviors (e.g., expanding HCV treatment for people who inject drugs, directly administered antiretroviral therapy, syringe services programs).